Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole Prophylaxis in Preterm and VLBW Neonates
NCT05848492Phase 3Completed
- Sponsor
- Services Institute of Medical Sciences
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluconazole in invasive candidiasis, sponsored by Services Institute of Medical Sciences. Primary endpoint: Incidence of invasive candidiasis at 2 weeks. Started May 2021; status: completed.
02
Drugs
fluconazole
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT05848492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05848492.